Semagacestat's fall: where next for AD therapies?

被引：19

作者：

Blennow, Kaj ^{[1
]}

Zetterberg, Henrik ^{[1
]}

Haass, Christian

机构：

[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden

来源：

NATURE MEDICINE | 2013年 / 19卷 / 10期

关键词：

GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE; PRESENILIN-1; TRIAL; BACE1; AGE;

D O I：

10.1038/nm.3365

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1214 / 1215

页数：2

共 16 条

[1] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, Kaj
Hampel, Harald
Weiner, Michael
Zetterberg, Henrik
[J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (03) : 131 - 144
[2] Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles
Cheret, Cyril
Willem, Michael
Fricker, Florence R.
Wende, Hagen
Wulf-Goldenberg, Annika
Tahirovic, Sabina
Nave, Klaus-Armin
Saftig, Paul
Haass, Christian
Garratt, Alistair N.
Bennett, David L.
Birchmeier, Carmen
[J]. EMBO JOURNAL, 2013, 32 (14) : 2015 - 2028
[3] A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, Rachelle S.
Raman, Rema
Farlow, Martin
Iwatsubo, Takeshi
Vellas, Bruno
Joffe, Steven
Kieburtz, Karl
He, Feng
Sun, Xiaoying
Thomas, Ronald G.
Aisen, Paul S.
Siemers, Eric
Sethuraman, Gopalan
Mohs, Richard
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) : 341 - 350
[4] Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease
Fleisher, Adam S.
Raman, Rema
Siemers, Eric R.
Becerra, Lida
Clark, Christopher M.
Dean, Robert A.
Farlow, Martin R.
Galvin, James E.
Peskind, Elaine R.
Quinn, Joseph F.
Sherzai, Abdullah
Sowell, Brooke
Aisen, Paul S.
Thal, Leon J.
[J]. ARCHIVES OF NEUROLOGY, 2008, 65 (08) : 1031 - 1038
[5] Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Holmes, Clive
Boche, Delphine
Wilkinson, David
Yadegarfar, Ghasem
Hopkins, Vivienne
Bayer, Anthony
Jones, Roy W.
Bullock, Roger
Love, Seth
Neal, James W.
Zotova, Elina
Nicoll, James A. R.
[J]. LANCET, 2008, 372 (9634) : 216 - 223
[6] A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Jonsson, Thorlakur
Atwal, Jasvinder K.
Steinberg, Stacy
Snaedal, Jon
Jonsson, Palmi V.
Bjornsson, Sigurbjorn
Stefansson, Hreinn
Sulem, Patrick
Gudbjartsson, Daniel
Maloney, Janice
Hoyte, Kwame
Gustafson, Amy
Liu, Yichin
Lu, Yanmei
Bhangale, Tushar
Graham, Robert R.
Huttenlocher, Johanna
Bjornsdottir, Gyda
Andreassen, Ole A.
Jonsson, Erik G.
Palotie, Aarno
Behrens, Timothy W.
Magnusson, Olafur T.
Kong, Augustine
Thorsteinsdottir, Unnur
Watts, Ryan J.
Stefansson, Kari
[J]. NATURE, 2012, 488 (7409) : 96 - 99
[7] Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
Kuhn, Peer-Hendrik
Koroniak, Katarzyna
Hogl, Sebastian
Colombo, Alessio
Zeitschel, Ulrike
Willem, Michael
Volbracht, Christiane
Schepers, Ute
Imhof, Axel
Hoffmeister, Albrecht
Haass, Christian
Rossner, Steffen
Braese, Stefan
Lichtenthaler, Stefan F.
[J]. EMBO JOURNAL, 2012, 31 (14) : 3157 - 3168
[8] FACILITATION OF LIN-12-MEDIATED SIGNALING BY SEL-12, A CAENORHABDITIS-ELEGANS S182 ALZHEIMERS-DISEASE GENE
LEVITAN, D
GREENWALD, I
[J]. NATURE, 1995, 377 (6547) : 351 - 354
[9] Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Orgogozo, JM
Gilman, S
Dartigues, JF
Laurent, B
Puel, M
Kirby, LC
Jouanny, P
Dubois, B
Eisner, L
Flitman, S
Michel, BF
Boada, M
Frank, A
Hock, C
[J]. NEUROLOGY, 2003, 61 (01) : 46 - 54
[10] A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
Portelius, Erik
Dean, Robert A.
Gustavsson, Mikael K.
Andreasson, Ulf
Zetterberg, Henrik
Siemers, Eric
Blennow, Kaj
[J]. ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (02):

← 1 2 →